About Dylan Sammut
Dylan joined Irving Levin in October 2018 as a Research and Editorial Associate and is responsible for reporting on mergers and acquisitions in the healthcare sector. He graduated from Alfred University in May 2014 with a degree in English and Political Science. He currently lives in Bridgeport, CT with his fiancé and his overweight cat, Kimba, and in his free time he plays video games, reads, writes, and hikes on the weekends all year around.
by Dylan Sammut | Nov 12, 2021 9:36 am | Behavioral Health Care
On November 5, Ventas, Inc. announced it acquired an Eating Recovery Center medical office building in Plano, Texas for $58 million. The building is a 102,000-square-foot facility with 72 inpatient beds. Founded in 1998, Ventas, Inc., owned by The Vanguard Group, is... Read More »
by Dylan Sammut | Nov 9, 2021 9:05 am | Healthcare Market Updates
What better way to get an understanding of the healthcare market than through the CEOs of the top companies themselves? Leaders across different segments, including hospitals, telehealth, managed care, home health and more, reported strong growth and activity and have... Read More »
by Dylan Sammut | Nov 9, 2021 9:05 am | Behavioral Health Care
Behavioral Health Group (BHG) has announced its recent acquisition of Staunton Treatment Center, a medication-assisted treatment facility located in Staunton, Virginia. Going forward, the center will operate under the name BHG Staunton Treatment Center. It has... Read More »
by Dylan Sammut | Nov 9, 2021 9:05 am | Healthcare Market Updates
Here we are again. Activity in October hit 212 deals, a slight uptick compared with 207 deals announced in September, but more than 50% higher compared with October 2020. It’s an all-time record for a single month, at least for now. Some activity last month can... Read More »
by Dylan Sammut | Nov 2, 2021 8:36 am | Physician Medical Groups
After more than five years as partners, Chicago Pacific Founders is exiting its investment in Pinnacle Dermatology. The private equity firm is selling its dermatology platform to BayPine, an investment firm based in Boston. No purchase price was disclosed in the... Read More »